Resmeitrom
-
Conshohocken-Based Madrigal’s Liver Disease Treatment Gets Priority Review by FDA
A Conshohocken-based pharmaceutical company’s treatment for nonalcoholic steatoheptatitis (NASH) a severe form of liver disease, is getting priority review by…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
